Development of polyion complex micelles for encapsulating and delivering amphotericin B

Biomaterials

Volumn 30, Issue 19, 2009, Pages 3352-3358

  Wang, Chau Hui ^a   Wang, Wei Ting ^b   Hsiue, Ging Ho ^b  

^a INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Amphotericin B; Poly(2 ethyl 2 oxazoline); Poly(aspartic acid); Polyion complex micelles

Indexed keywords

AMPHOTERICIN B; ANTI-FUNGAL DRUGS; ANTIFUNGAL ANTIBIOTICS; CANDIDA ALBICANS; CORE-SHELL STRUCTURES; FUNGAL INFECTIONS; IN-VITRO; POLY(2-ETHYL-2-OXAZOLINE); POLY(ASPARTIC ACID); POLYION COMPLEX MICELLES; PROLONGED RELEASE; TEM;

BLOCK COPOLYMERS; NITROGEN COMPOUNDS; ORGANIC ACIDS; ORGANIC POLYMERS; POLYMERS; SIGNAL INTERFERENCE;

MICELLES;

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; DRUG CARRIER; POLY(2 ETHYL 2 OXAZOLINE)BLOCK POLY(ASPARTIC ACID); UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG POTENCY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; MICELLE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPARTIC ACID; BIOCOMPATIBLE MATERIALS; CANDIDA ALBICANS; CELL LINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; IONS; MATERIALS TESTING; MICELLES; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; OXAZOLES; POLYMERS;

CANDIDA ALBICANS;

EID: 67349238221     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.02.041     Document Type: Article

References (40)

1. Gallis H.A., Drew R.H., and Pickard W.W. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 12 (1990) 308-329
2. Clemons K.V., and Stevens D.A. Comparative efficacies of four amphotericin B formulations-fungizone, amphotec (amphocil), ambisome, and abelcet-against systemic murine aspergillosis. Antimicrobial Agents Chemother 48 (2004) 1047-1050
3. Cleary J.D., Rogers P.D., and Chapman S.W. Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulations. Pharmacotherapy 23 (2003) 572-578
4. Brajtburg J., and Bolard J. Carrier effects on biological activity of amphotericin B. Clin Microbiol Rev 9 (1996) 512-531
5. Dupont B. Overview of the lipid formulations of amphotericin B. J Antimicrob Chemother 49 (2002) 31-36
6. Boswell G.W., Bekersky I., Buell D., Hiles R., and Walsh T.J. Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats. Antimicrobial Agents Chemother 42 (1998) 263-268
7. Boswell G.W., Buell D., and Bekersky I. AmBisome (liposomal amphotericin B): a comparative review. J Clin Pharmacol 38 (1998) 583-592
8. Walsh T.J., Yeldandi V., McEvoy M., Gonzalez C., Chanock S., Freifeld A., et al. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrobial Agents Chemother 42 (1998) 2391-2398
9. Kwon G.S., and Kataoka K. Block copolymer micelles as long-circulating drug vehicles. Adv Drug Deliv Rev 16 (1995) 295-309
10. Yu B.G., Okano T., Kataoka K., Sardari S., and Kwon G.S. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta-benzyl-l-aspartate) micelles. J Control Release 56 (1998) 285-291
11. Yu B.G., Okano T., Kataoka K., and Kwon G. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B. J Control Release 53 (1998) 131-136
12. Yokoyama M., Kwon G.S., Okano T., Sakurai Y., Naito M., and Kataoka K. Influencing factors on in-vitro micelle stability of adriamycin-block copolymer conjugates. J Control Release 28 (1994) 59-65
13. Harada A., and Kataoka K. Supramolecular assemblies of block copolymers in aqueous media as nanocontainers relevant to biological applications. Prog Polym Sci 31 (2006) 949-982
14. Matsumura Y. Poly(amino acid) micelle nanocarriers in preclinical and clinical studies. Adv Drug Deliv Rev 60 (2008) 899-914
15. Kataoka K., Harada A., and Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47 (2001) 113-131
16. Allen C., Maysinger D., and Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B Biointerfaces 16 (1999) 3-27
17. Yokoyama M., Kwon G.S., Okano T., Sakurai Y., Seto T., and Kataoka K. Preparation of micelle-forming polymer drug conjugates. Bioconjuate Chem 3 (1992) 295-301
18. Li Y., and Kwon G.S. Micelle-like structures of poly(ethylene oxide)-block-poly(2-hydroxyetbyl aspartamide)-methotrexate conjugates. Colloids Surf B Biointerfaces 16 (1999) 217-226
19. Wang C.H., Wang C.H., and Hsiue G.H. Polymeric micelles with a pH-responsive structure as intracellular drug carriers. J Control Release 108 (2005) 140-149
20. Hsiue G.H., Wang C.H., Lo C.L., Wang C.H., Li J.P., and Yang J.L. Environmental-sensitive micelles based on poly(2-ethyl-2-oxazoline)-b-poly(l-lactide) diblock copoly-mer for application in drug delivery. Int J Pharm 317 (2006) 69-75
21. Hiemenz J.W., and Walsh T.J. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 22 (1996) S133-S144
22. Wong-Beringer A., Jacobs R.A., and Guglielmo B.J. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis 27 (1998) 603-618
23. Zalipsky S., Hansen C.B., Oaks J.M., and Allen T.M. Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes. J Pharm Sci 85 (1996) 133-137
24. Harada A., and Kataoka K. Formation of stable and monodispersive polyion complex micelles in aqueous medium from poly(l-lysine) and poly(ethylene glycol)-poly(aspartic acid) block copolymer. J Macromol Sci Part A Pure Appl Chem 34 (1997) 2119-2133
25. Roweton S., Huang S.J., and Swift G. Poly(aspartic acid): synthesis, biodegradation, and current applications. J Environ Polym Degrad 5 (1997) 175-181
26. Govender T., Stolnik S., Xiong C.D., Zhang S., Illum L., and Davis S.S. Drug-polyionic block copolymer interactions for micelle formation: physicochemical characterisation. J Control Release 75 (2001) 249-258
27. Kobayashi S., Masuda E., Shoda S., and Shimano Y. Synthesis of acryl- and methacryl-type macromonomers and telechelics by utilizing living polymerization of 2-oxazolines. Macromolecules 22 (1989) 2878-2884
28. Ouchi T., Miyazaki H., Arimura H., Tasaka F., Hamada A., and Ohya Y. Synthesis of biodegradable amphiphilic AB-type diblock copolymers of lactide and depsipeptide with pendant reactive groups. J Polym Sci Part A Polym Chem 40 (2002) 1218-1225
29. Shibanuma T., Aoki T., Sanui K., Ogata N., Kikuchi A., Sakurai Y., et al. Thermosensitive phase-separation behavior of poly(acrylic acid)-graft-poly(N,N-dimethyl-acrylamide) aqueous solution. Macromolecules 33 (2000) 444-450
30. Bangham A.D., Standish M.M., and Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13 (1965) 238-252
31. Mourtas S., Fotopoulou S., Duraj S., Sfika V., Tsakiroglou C., and Antimisiaris S.G. Liposomal drugs dispersed in hydrogels: effect of liposome, drug and gel properties on drug release kinetics. Colloids Surf B Biointerfaces 55 (2007) 212-221
32. Chen W., Chen H.R., Hu J.H., Yang W.L., and Wang C.C. Synthesis and characterization of polyion complex micelles between poly(ethylene glycol)-grafted poly(aspartic acid) and cetyltrimethyl ammonium bromide. Colloids Surf A Physicochem Eng Asp 278 (2006) 60-66
33. Espuelas M.S., Legrand P., Campanero M.A., Appel M., Cheron M., Gamazo C., et al. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice. J Antimicrob Chemother 52 (2003) 419-427
34. Espuelas M.S., Legrand P., Loiseau P.M., Bories C., Barratt G., and Irache J.M. In vitro antileishmanial activity of amphotericin B loaded in poly(epsilon-caprolactone) nanospheres. J Drug Target 10 (2002) 593-599
35. Tasset C., Goethals F., Pŕeat V., and Roland M. Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(ε-caprolactone-co-trimethylenecarbonate) polymeric micelles. Int J Pharm 58 (1990) 41-48
36. Gross R.A., and Kalra B. Biodegradable polymers for the environment. Science 297 (2002) 803-806
37. Brazel C.S., and Peppas N.A. Synthesis and characterization of thermo- and chemo-mechanically responsive poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels. Macromolecules 28 (1995) 8016-8020
38. Kwon I.C., Bae Y.H., and Kim S.W. Electrically erodible polymer gel controlled release of drugs. Nature 354 (1991) 291-294
39. Wang C.H., and Hsiue G.H. New amphiphilic poly(2-ethyl-2-oxazoline)/poly(l-lactide) triblock copolymers. Biomacromolecules 4 (2003) 1487-1490
40. Christova D., Velichkova R., Loos W., Goethals E.J., and Prez F.D. New thermo-responsive polymer materials based on poly(2-ethyl-2-oxazoline) segments. Polymer 44 (2003) 2255-2261